Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 33914026
Erasmus JC, et al. (2021) Rac1-PAK1 regulation of Rab11 cycling promotes junction destabilization. J Cell Biol 220 33914026
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T551-p - CTNNB1 (human)
Modsite: HQDTQRRtSMGGTQQ SwissProt Entrez-Gene
Orthologous residues
CTNNB1 (human): T551‑p, CTNNB1 (mouse): T551‑p, CTNNB1 (rat): T551‑p, CTNNB1 (rabbit): T551‑p
Characterization
Methods used to characterize site in vivo mass spectrometry (in vitro), mutation of modification site

S552-p - CTNNB1 (human)
Modsite: QDTQRRTsMGGTQQQ SwissProt Entrez-Gene
Orthologous residues
CTNNB1 (human): S552‑p, CTNNB1 (mouse): S552‑p, CTNNB1 (rat): S552‑p, CTNNB1 (rabbit): S552‑p
Characterization
Methods used to characterize site in vivo mass spectrometry (in vitro), mutation of modification site

S675-p - CTNNB1 (human)
Modsite: QDYKKRLsVELTSSL SwissProt Entrez-Gene
Orthologous residues
CTNNB1 (human): S675‑p, CTNNB1 (mouse): S675‑p, CTNNB1 (rat): S675‑p, CTNNB1 (rabbit): S675‑p
Characterization
Methods used to characterize site in vivo immunoassay, mass spectrometry (in vitro), mutation of modification site, phospho-antibody
Relevant cell lines - cell types - tissues:  keratinocyte
Cellular systems studied:  primary cells
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE PAK1 (human)
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
CDH1 (human) Induces in vitro

T248-p - GDI2 (human)
Modsite: LSAIYGGtYMLNKPI SwissProt Entrez-Gene
Orthologous residues
GDI2 (human): T248‑p, GDI2 iso2 (human): T203‑p, GDI2 (mouse): T248‑p, GDI2 (rat): T248‑p
Characterization
Enzymes shown to modify site in vitro
Type Enzyme
KINASE PAK1 (human)

S382-p - GDI2 (human)
Modsite: PIEQKFVsISDLLVP SwissProt Entrez-Gene
Orthologous residues
GDI2 (human): S382‑p, GDI2 iso2 (human): S337‑p, GDI2 (mouse): S382‑p, GDI2 (rat): S382‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Relevant cell lines - cell types - tissues:  keratinocyte
Cellular systems studied:  primary cells
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE PAK1 (human)
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
RAB5A (human) Induces co-immunoprecipitation
RAB11A (human) Induces intracellular localization co-immunoprecipitation